Pharmaceutical

Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Access and buy GlobalData’s databook on the latest filings and grants activity for Kiniksa Pharmaceuticals here.

Jul 22, 2024 - 04:00
Kiniksa Pharmaceuticals sees highest patent filings and grants during April in Q2 2024
Access and buy GlobalData’s databook on the latest filings and grants activity for Kiniksa Pharmaceuticals here.
Read the original article

Tags:

Previous Article

Medicover sees highest patent filings and grants during May in Q2 2024

Next Article

Y-mAbs Therapeutics sees highest patent filings and grants during June in Q2 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Nuvectis Pharma receives IND approval from FDA for NXP900

Nuvectis Pharma receives IND approval from FDA for NXP900

May 16, 2023

STAT+: Biotech launches with $82 million for Parkinson’s cell therapy

STAT+: Biotech launches with $82 million for Parkinson’...

Feb 29, 2024

FDA urged to move faster to fix pulse oximeters for darker-skinned patients

FDA urged to move faster to fix pulse oximeters for dar...

Feb 3, 2024